Category: Moderna
USA: Florida recommends against males aged 18 to 39 receiving mRNA COVID-19 vaccines
“The State Surgeon General recommends against males aged 18 to 39 from receiving mRNA COVID-19 vaccines.” More...
Preprint: Reevaluation of antibody-dependent enhancement for SARS-CoV-2 treatments
A new preprint looking at the evidence for antibody-dependent enhancement (ADE) is getting a LOT of attention online – we link to it below so that you can read it for yourself. More...
Italy: Mandatory self-isolation for Covid-19 returns
Italy is ramping up its Covid-19 winter wave preparations by announcing the return of mandatory self-isolation for those who test positive for the virus. More...
Preprint: Serious Adverse Events of Special Interest Following mRNA Vaccination in Randomized Trials
“The excess risk of serious adverse events of special interest surpassed the risk reduction for COVID-19 hospitalization relative to the placebo group in both Pfizer and Moderna trials.” More...
Germany: Fourth Covid vaccination offered for “a quieter and symptom-free summer”
Germany’s health minister Karl Lauterbach has announced plans to offer every citizen a fourth Covid vaccination so that they can have “a quieter and symptom-free summer”. More...
Israel: Fifth Covid-19 vaccination under consideration
A fifth round of Covid vaccinations is under consideration in Israel, according to the Jerusalem Post. More...
Moderna looks at producing a Monkeypox vaccine
Moderna is considering turning its mRNA vaccine platform towards finding a vaccine to defend against Monkeypox, according to a recent tweet by the company. More...
Preprint: Enhanced Fusogenicity of BA.4, BA.5 and BA.2.12.1
“We found that the new Omicron subvariants BA.4/5 and BA.2.12.1 were more resistant to neutralization by mRNA-vaccinated and boosted health care worker sera and Omicron-BA.1-wave patient sera than were the BA.1 and BA.2 variants.” More...
Preprint: SARS-CoV-2 vaccination can elicit a CD8 T-cell dominant hepatitis
“Here, we report the case of a 52-year-old male, presenting with bimodal episodes of acute hepatitis, each occurring 2-3 weeks after BNT162b2 mRNA vaccination and sought to identify the underlying immune correlates. More...
Spain: Fully boosted healthcare worker reinfected with SARs-CoV-2 after just 20 days
A fully boosted 31-year-old Spanish woman has contracted two different SARS-CoV-2 variants within three weeks. More...